Anemia is the most prevalent blood condition in the U.S. Annually, the condition accounts for 2.8 million visits to physician offices with anemia as the primary diagnosis, according the Centers for ...

Even though anemia is not as common in the United States (affecting roughly 10 percent of people) as it is worldwide (affecting nearly 30 percent of people), it often affects more women than men and ...

Sickle cell anemia is an inherited condition that impacts red blood cells. It can cause a variety of symptoms, which may include anemia, infections, and blockages in blood vessels. Sickle cell disease ...

People with the thalassemia trait, or thalassemia carriers, may not experience any symptoms. However, some thalassemia carriers can experience anemia symptoms, such as paleness and fatigue. In people ...

Anemia affects 1 in 5 older adults but is often undiagnosed or misattributed. Oral iron remains first-line treatment, though IV infusions help many patients. Low hemoglobin levels may signal ...

Anemia is more common in later-stage chronic kidney disease (CKD), with diabetes and dialysis increasing the risk. Treating the underlying cause can improve symptoms and quality of life. It’s ...

INDIANAPOLIS (WISH)– Iron deficiency anemia, a common nutritional deficiency, often goes undiagnosed due to its vague symptoms, according to Dr. Mukul Singal from Innovative Hematology. Dr. Singal ...

While anemia is not a typical symptom of IBS, people with IBS may develop anemia if they cannot absorb enough iron from their food. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder ...

People with anemia — the insufficient amount of red blood cells — are more likely to experience long-term COVID-19 symptoms even after the infection has been cleared from their immune system, ...

Please provide your email address to receive an email when new articles are posted on . Numerous conditions can lead to depression in patients with advanced chronic kidney disease. Patients should be ...

Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions. Ojjaara (momelotinib) is the first treatment of ...